A. E. EŞKAZAN And A. GÜNDÜZ, "What is the best treatment approach for sporadic late-onset nemaline myopathy associated with "monoclonal gammopathy of neurological significance"?," INTERNATIONAL JOURNAL OF CANCER , vol.148, no.11, pp.2638-2639, 2021
EŞKAZAN, A. E. And GÜNDÜZ, A. 2021. What is the best treatment approach for sporadic late-onset nemaline myopathy associated with "monoclonal gammopathy of neurological significance"?. INTERNATIONAL JOURNAL OF CANCER , vol.148, no.11 , 2638-2639.
EŞKAZAN, A. E., & GÜNDÜZ, A., (2021). What is the best treatment approach for sporadic late-onset nemaline myopathy associated with "monoclonal gammopathy of neurological significance"?. INTERNATIONAL JOURNAL OF CANCER , vol.148, no.11, 2638-2639.
EŞKAZAN, Ahmet, And Ayşegül GÜNDÜZ. "What is the best treatment approach for sporadic late-onset nemaline myopathy associated with "monoclonal gammopathy of neurological significance"?," INTERNATIONAL JOURNAL OF CANCER , vol.148, no.11, 2638-2639, 2021
EŞKAZAN, Ahmet E. And GÜNDÜZ, Ayşegül. "What is the best treatment approach for sporadic late-onset nemaline myopathy associated with "monoclonal gammopathy of neurological significance"?." INTERNATIONAL JOURNAL OF CANCER , vol.148, no.11, pp.2638-2639, 2021
EŞKAZAN, A. E. And GÜNDÜZ, A. (2021) . "What is the best treatment approach for sporadic late-onset nemaline myopathy associated with "monoclonal gammopathy of neurological significance"?." INTERNATIONAL JOURNAL OF CANCER , vol.148, no.11, pp.2638-2639.
@article{article, author={Ahmet Emre EŞKAZAN And author={Ayşegül GÜNDÜZ}, title={What is the best treatment approach for sporadic late-onset nemaline myopathy associated with "monoclonal gammopathy of neurological significance"?}, journal={INTERNATIONAL JOURNAL OF CANCER}, year=2021, pages={2638-2639} }